NATCO PHARMA LTD INR 2.0's ticker is and the CUSIP is Y6211C157. A total of 1 filers reported holding NATCO PHARMA LTD INR 2.0 in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $679,619 | +1.3% | 99,144 | 0.0% | 0.12% | -5.5% |
| Q4 2022 | $671,166 | -9.2% | 99,144 | 0.0% | 0.13% | -8.6% |
| Q3 2022 | $739,000 | -9.4% | 99,144 | 0.0% | 0.14% | -3.4% |
| Q2 2022 | $816,000 | -17.5% | 99,144 | 0.0% | 0.14% | +5.8% |
| Q1 2022 | $989,000 | -17.9% | 99,144 | 0.0% | 0.14% | -3.5% |
| Q4 2021 | $1,205,000 | +1.3% | 99,144 | 0.0% | 0.14% | -8.4% |
| Q3 2021 | $1,189,000 | -21.2% | 99,144 | 0.0% | 0.16% | -27.9% |
| Q2 2021 | $1,509,000 | +35.1% | 99,144 | 0.0% | 0.22% | +16.8% |
| Q1 2021 | $1,117,000 | -14.1% | 99,144 | 0.0% | 0.18% | -20.0% |
| Q4 2020 | $1,300,000 | +2.4% | 99,144 | 0.0% | 0.23% | -17.9% |
| Q3 2020 | $1,270,000 | – | 99,144 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stanley-Laman Group, Ltd. | 99,144 | $989,000 | 0.14% |